ArticleBreast cancer research : BCR2019

Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer.

Agnieszka Morgenroth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.